Nicholas Kennedy

Has grant

Honorary Clinical Senior Lecturer

University of Exeter

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Nicholas Kennedy is an Honorary Clinical Senior Lecturer at the University of Exeter, United Kingdom. His research focuses on inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, emphasizing the efficacy of various treatment modalities and innovative management strategies. Recent publications include systematic reviews, cost-utility analyses, and studies on the predictors of therapy responsiveness, contributing significantly to the field of precision medicine and patient care in gastroenterology.

Recent Grants

Grant: Close

IBD-RESPONSE: Defining microbial predictors of responsiveness to biological therapies in Crohn's disease and ulcerative colitis

Open Date: 2021-01-01

Close Date: 2024-12-31

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (17)

Natalie Prescott

King’s College London

UNITED KINGDOM

Nicholas Kennedy

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCT

Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn’s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis

Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England

Defining predictors of responsiveness to advanced therapies in Crohn’s disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine

Cross-sectional evaluation of online direct-to-public calprotectin testing

Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study

The importance of high-quality ‘big data’ in the application of artificial intelligence in inflammatory bowel disease

Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease

Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement project

Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic

Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: Secondary analysis of a nationwide electronic survey

Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?

Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic

Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: Insights from a multicentre UK cohort study

Collaborators (17)

Natalie Prescott

Anjan Dhar

Tim Raine

Sreedhar Subramanian

Stephen Hanauer

J. R. Fraser Cummings

Nick Powell

Rebecca Maier

Alessandro Armuzzi

Shaji Sebastian

Keith Bodger

Peter Irving

Craig Mowat

Neeraj Bhala

Jonathan Macdonald

Matthew Brookes

Christopher A. Lamb

Make your next move.